Your browser doesn't support javascript.
loading
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.
Yan, TingDong; Ooi, Wen Fong; Qamra, Aditi; Cheung, Alice; Ma, DongLiang; Sundaram, Gopinath Meenakshi; Xu, Chang; Xing, Manjie; Poon, LaiFong; Wang, Jing; Loh, Yan Ping; Ho, Jess Hui Jie; Ng, Joscelyn Jun Quan; Ramlee, Muhammad Khairul; Aswad, Luay; Rozen, Steve G; Ghosh, Sujoy; Bard, Frederic A; Sampath, Prabha; Tergaonkar, Vinay; Davies, James O J; Hughes, Jim R; Goh, Eyleen; Bi, Xuezhi; Fullwood, Melissa Jane; Tan, Patrick; Li, Shang.
Afiliação
  • Yan T; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Ooi WF; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, 60 Biopolis Street, Singapore, 138672, Singapore.
  • Qamra A; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, 60 Biopolis Street, Singapore, 138672, Singapore.
  • Cheung A; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore, 117597, Singapore.
  • Ma D; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Sundaram GM; Neuroscience Academic Clinical Programme, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Xu C; Department of Research, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
  • Xing M; Institute of Medical Biology (IMB), 8A Biomedical Grove, Singapore, 138648, Singapore.
  • Poon L; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Wang J; Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
  • Loh YP; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Ho JHJ; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, 60 Biopolis Street, Singapore, 138672, Singapore.
  • Ng JJQ; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Ramlee MK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Aswad L; Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
  • Rozen SG; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.
  • Ghosh S; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Bard FA; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Sampath P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Tergaonkar V; Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
  • Davies JOJ; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.
  • Hughes JR; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Goh E; Duke-NUS Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Bi X; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Fullwood MJ; Institute of Molecular and Cell Biology (IMCB), Singapore, 138673, Singapore.
  • Tan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
  • Li S; Institute of Medical Biology (IMB), 8A Biomedical Grove, Singapore, 138648, Singapore.
Nat Commun ; 9(1): 100, 2018 01 08.
Article em En | MEDLINE | ID: mdl-29311615
ABSTRACT
The repression of telomerase activity during cellular differentiation promotes replicative aging and functions as a physiological barrier for tumorigenesis in long-lived mammals, including humans. However, the underlying mechanisms remain largely unclear. Here we describe how miR-615-3p represses hTERT expression. mir-615-3p is located in an intron of the HOXC5 gene, a member of the highly conserved homeobox family of transcription factors controlling embryogenesis and development. Unexpectedly, we found that HoxC5 also represses hTERT expression by disrupting the long-range interaction between hTERT promoter and its distal enhancer. The 3'UTR of hTERT and its upstream enhancer region are well conserved in long-lived primates. Both mir-615-3p and HOXC5 are activated upon differentiation, which constitute a feed-forward loop that coordinates transcriptional and post-transcriptional repression of hTERT during cellular differentiation. Deregulation of HOXC5 and mir-615-3p expression may contribute to the activation of hTERT in human cancers.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diferenciação Celular / Transformação Celular Neoplásica / Proteínas de Homeodomínio / Telomerase / MicroRNAs Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diferenciação Celular / Transformação Celular Neoplásica / Proteínas de Homeodomínio / Telomerase / MicroRNAs Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article